Monoclonal antibodies reveal that certain myeloid antigens in childhood leukemia indicate a poor prognosis. Conversely, T-cell markers suggest a better outcome, guiding individualized cancer therapy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: